Meilleure Health International Industry Group Balance Sheet Health
Financial Health criteria checks 5/6
Meilleure Health International Industry Group has a total shareholder equity of HK$1.2B and total debt of HK$289.9M, which brings its debt-to-equity ratio to 23.8%. Its total assets and total liabilities are HK$1.7B and HK$445.5M respectively. Meilleure Health International Industry Group's EBIT is HK$13.5M making its interest coverage ratio -1.7. It has cash and short-term investments of HK$6.6M.
Key information
23.8%
Debt to equity ratio
HK$289.94m
Debt
| Interest coverage ratio | -1.7x |
| Cash | HK$6.64m |
| Equity | HK$1.22b |
| Total liabilities | HK$445.49m |
| Total assets | HK$1.66b |
Recent financial health updates
Meilleure Health International Industry Group (HKG:2327) Has A Somewhat Strained Balance Sheet
Aug 30
Is Meilleure Health International Industry Group (HKG:2327) A Risky Investment?
Sep 06Does Meilleure Health International Industry Group (HKG:2327) Have A Healthy Balance Sheet?
Sep 09Meilleure Health International Industry Group (HKG:2327) Seems To Use Debt Rather Sparingly
Apr 18Recent updates
Meilleure Health International Industry Group's (HKG:2327) Shareholders May Want To Dig Deeper Than Statutory Profit
Oct 04Earnings Not Telling The Story For Meilleure Health International Industry Group Limited (HKG:2327) After Shares Rise 34%
Sep 05Meilleure Health International Industry Group (HKG:2327) Has A Somewhat Strained Balance Sheet
Aug 30Meilleure Health International Industry Group Limited's (HKG:2327) 31% Share Price Plunge Could Signal Some Risk
Jul 19Meilleure Health International Industry Group (HKG:2327) Will Be Hoping To Turn Its Returns On Capital Around
Jun 17Optimistic Investors Push Meilleure Health International Industry Group Limited (HKG:2327) Shares Up 32% But Growth Is Lacking
May 03Meilleure Health International Industry Group's (HKG:2327) Earnings Are Of Questionable Quality
Apr 04Some Confidence Is Lacking In Meilleure Health International Industry Group Limited (HKG:2327) As Shares Slide 30%
Feb 28Returns Are Gaining Momentum At Meilleure Health International Industry Group (HKG:2327)
Jan 23Returns At Meilleure Health International Industry Group (HKG:2327) Appear To Be Weighed Down
Aug 17Investors Met With Slowing Returns on Capital At Meilleure Health International Industry Group (HKG:2327)
Oct 18Is Meilleure Health International Industry Group (HKG:2327) A Risky Investment?
Sep 06Investors Will Want Meilleure Health International Industry Group's (HKG:2327) Growth In ROCE To Persist
Jul 12Does Meilleure Health International Industry Group (HKG:2327) Have A Healthy Balance Sheet?
Sep 09Meilleure Health International Industry Group (HKG:2327) Shareholders Will Want The ROCE Trajectory To Continue
May 15Meilleure Health International Industry Group (HKG:2327) Seems To Use Debt Rather Sparingly
Apr 18Did You Miss Meilleure Health International Industry Group's (HKG:2327) Impressive 124% Share Price Gain?
Jan 29
Here's What We Think About Meilleure Health International Industry Group's (HKG:2327) CEO Pay
Dec 08Financial Position Analysis
Short Term Liabilities: 2327's short term assets (HK$700.1M) exceed its short term liabilities (HK$236.1M).
Long Term Liabilities: 2327's short term assets (HK$700.1M) exceed its long term liabilities (HK$209.4M).
Debt to Equity History and Analysis
Debt Level: 2327's net debt to equity ratio (23.2%) is considered satisfactory.
Reducing Debt: 2327's debt to equity ratio has reduced from 31.3% to 23.8% over the past 5 years.
Debt Coverage: 2327's debt is not well covered by operating cash flow (19.3%).
Interest Coverage: 2327 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/15 09:56 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Meilleure Health International Industry Group Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Li Wu | Tianfeng Securities Brokerage Co., Ltd |